Page last updated: 2024-09-05

ly 353381 and ibandronic acid

ly 353381 has been researched along with ibandronic acid in 1 studies

Compound Research Comparison

Studies (ly 353381)	Trials (ly 353381)	Recent Studies (post-2010) (ly 353381)	Studies (ibandronic acid)	Trials (ibandronic acid)	Recent Studies (post-2010) (ibandronic acid)
70	12	15	794	184	306

Protein Interaction Comparison

Protein	Taxonomy	ly 353381 (IC50)	ibandronic acid (IC50)
Farnesyl pyrophosphate synthase	Homo sapiens (human)		0.4112

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biskobing, DM; Downs, R; Novy, AM	1

Reviews

1 review(s) available for ly 353381 and ibandronic acid

Article	Year
Novel therapeutic options for osteoporosis. Current opinion in rheumatology, 2002, Volume: 14, Issue:4 Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid	2002

Article

Year

Novel therapeutic options for osteoporosis.

Current opinion in rheumatology, 2002, Volume: 14, Issue:4

Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid

2002